WCM
RCEL icon

WealthTrak Capital Management’s Avita Medical RCEL Stock Holding History

WealthTrak Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25
Closed -$320 – 1088
2024
Q4 		$320 Buy
+25
New +$295 ﹤0.01% 699

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

WealthTrak Capital Management's RCEL Position: Q1 2025 in Review

WealthTrak Capital Management sold out of Avita Medical (RCEL) in Q1 2025, closing a stake of 25 shares — an estimated $320 sold.

WealthTrak Capital Management first reported a position in RCEL in Q4 2024 and held it in 1 quarter. The position peaked at $320 in Q4 2024. 74 funds tracked by Wall St. Rank hold RCEL as of Q1 2025.

  • WealthTrak Capital Management reported no remaining Avita Medical position as of Q1 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 25 Avita Medical shares in Q1 2025, an estimated $320.
  • WealthTrak Capital Management first reported a position in Avita Medical in Q4 2024 and held it in 1 quarter.
  • WealthTrak Capital Management's Avita Medical position peaked at $320 in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q1 2025.

Based on WealthTrak Capital Management's 13F filing for Q1 2025, filed 15 May 2025.